23 01, 2023 Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseasesNeal Evan Caminsky2023-01-23T10:01:17-05:00January 23, 2023|Funded Research Results, Pillar 4|
7 07, 2022 Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseasesNeal Evan Caminsky2022-11-15T09:12:18-05:00July 7, 2022|Funded Research Results, Pillar 4|
10 05, 2022 Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-BNeal Evan Caminsky2022-11-15T09:13:56-05:00May 10, 2022|Funded Research Results, Pillar 4|
